Number of the records: 1  

Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection

  1. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection  / Z. J. Liu ... [et al.] .  Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 64, no. 5 (2017), s. 795-802  : ilustr., grafy, tab.  
    C 720
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.